EDGAR Filing Documents for 0001193125-16-746772

Form 8-K - Current report:

SEC Accession No. 0001193125-16-746772

Filing Date

2016-10-25

Accepted

2016-10-25 17:20:34

Documents

Period of Report

2016-10-25

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d273742d8k.htm	8-K	43348
2	EX-4.1	d273742dex41.htm	EX-4.1	750599
3	EX-99.1	d273742dex991.htm	EX-99.1	986617
4	EX-99.2	d273742dex992.htm	EX-99.2	19833
5	GRAPHIC	g273742logo.jpg	GRAPHIC	7478
	Complete submission text file	0001193125-16-746772.txt		1812310

Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4

Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100

Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)